'Mad Money Lightning Round': Go With Exelixis

To see the full "Mad Money" Recap, please click here .


NEW YORK ( TheStreet) -- Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Tuesday evening.

Exelixis ( EXEL): "I think these companies are terrific bets and I want to be in this one."

Photronics ( PLAB): "It's too rocky a road. I don't like tech until September. I wouldn't recommend it until then."

Buckeye Partners ( BPL): "Oh yes! This is exactly what you should be buying. Great yield."

PPL Corp ( PPL): "It's very reliable and very good, and I'd buy it right here."

GlaxoSmithKline ( GSK): "It's near a 52-week high. It doesn't have the growth of some of the others, but I think it's a good stock."

--Written by Scott Rutt in Washington, D.C.

To contact the writer of this article, click here: Scott Rutt.

To follow the writer on Twitter, go to http://twitter.com/scottrutt.

To submit a news tip, send an email to: tips@thestreet.com.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

*For all you home-gamers, a 'mon-back opportunity means Cramer would back up the figurative truck and load up on a stock.

Want more Cramer? Check out Jim's rules and commandments for investing by clicking here.

If you liked this article you might like

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis

Carnival, Tableau Software, Groupon, Newell Brands: 'Mad Money' Lightning Round

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Exelixis Has an Enviable Chart Pattern

Biotech Movers: Exelixis, Omeros, Inovio